SCHEMBL423131

SCHEMBL423131

[CH2]CCCCC(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6434209 0.97 TRPV1 (0.40)
SCHEMBL21694371 0.97 TRPV1 (0.40)
SCHEMBL421671 0.97
SCHEMBL7862202 0.97 TRPV1 (0.40)
SCHEMBL6440275 0.97 TRPV1 (0.40)
SCHEMBL6440333 0.97 TRPV1 (0.40)
SCHEMBL21694380 0.97 TRPV1 (0.40)
SCHEMBL22472150 0.97 TRPV1 (0.40)
SCHEMBL755558 0.91
SCHEMBL270172 0.91

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 308 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240180932-A1 SUBSTITUTED RESORCYLIC ACID COMPOUNDS IN THE MANAGEMENT OF AGEING AND RELATED DISORDERS NESTLE SA (CH) 2024-06-06 US claimed
EP-4313017-A1 SUBSTITUTED RESORCYLIC ACID COMPOUNDS IN THE MANAGEMENT OF AGEING AND RELATED DISORDERS Société des Produits Nestlé S.A. (CH) 2024-02-07 EP claimed
US-20240010589-A1 SUBSTITUTED RESORCINOL COMPOUNDS AS AMPK ACTIVATORS, COMPOSITIONS, METHODS AND USES THEREOF NESTLE SA (CH) 2024-01-11 US claimed
US-20230414638-A1 SUBSTITUTED RESORCYLIC ACID COMPOUNDS AS AMPK ACTIVATOR AND USES THEREOF NESTLE SA (CH) 2023-12-28 US claimed
WO-2023213715-A1 AMPK ACTIVATOR (CBDA) AND SGLT2 INHIBITOR FOR METABOLIC HEALTH Société des Produits Nestlé S.A. (CH) 2023-11-09 WO claimed
CN-116981452-A Substituted resorcinol compounds for the management of aging and related disorders 雀巢产品有限公司 2023-10-31 CN claimed
EP-4247359-A1 SUBSTITUTED RESORCINOL COMPOUNDS AS AMPK ACTIVATORS, COMPOSITIONS, METHODS AND USES THEREOF Société des Produits Nestlé S.A. (CH) 2023-09-27 EP claimed
CN-116761791-A Substituted resorcinol compounds as AMPK activators and uses thereof 雀巢产品有限公司 2023-09-15 CN claimed
EP-4240342-A1 SUBSTITUTED RESORCYLIC ACID COMPOUNDS AS AMPK ACTIVATOR AND USES THEREOF Société des Produits Nestlé S.A. (CH) 2023-09-13 EP claimed
CN-116744911-A Substituted resorcinol compounds as AMPK activators, compositions, methods and uses thereof 雀巢产品有限公司 2023-09-12 CN claimed
US-5648357-A MAINTAINING HOMEOSTASIS IN RESPONSE TO INFLAMMATORY AND PROLIFERATIVE STIMULI CELL THERAPEUTICS, INC. (US) 1997-07-15 US claimed
EP-0584347-A4 ENANTIOMERIC HYDROXYLATED XANTHINE COMPOUNDS. CELL THERAPEUTICS INC (US) 1995-04-26 EP claimed
CN-1085557-A The enantiomorph hydroxylated xanthine compounds CELL THERAPEUTICS INC (US) 1994-04-20 CN claimed
EP-0584347-A1 ENANTIOMERIC HYDROXYLATED XANTHINE COMPOUNDS CELL THERAPEUTICS, INC. (US) 1994-03-02 EP claimed
WO-1993017684-A2 ENANTIOMERIC HYDROXYLATED XANTHINE COMPOUNDS CELL THERAPEUTICS, INC. (US) 1993-09-16 WO claimed
US-5047432-A Antidepressants THE BOOTS COMPANY PLC (GB) 1991-09-10 US claimed
US-4882082-A PYRIMIDINE DERIVATIVE LIQUID CRYSTALS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1989-11-21 US claimed
EP-0191542-B1 ARYLCYCLOBUTYLALKYL AMINES AND THEIR USE AS ANTIDEPRESSIVE MEDICINES The Boots Company PLC (GB) 1988-06-08 EP claimed
CN-86100954-A The preparation method of therapeutical agent and application 1986-09-03 CN claimed
EP-0191542-A1 Arylcyclobutylalkyl amines and their use as antidepressive medicines The Boots Company PLC (GB) 1986-08-20 EP claimed